The tech giant and the health IT security company have teamed up to develop an identity and access management cloud platform for the healthcare industry.
Microsoft and health IT security company Imprivata have teamed up to create an identity and access management cloud platform for the healthcare industry.
The solution pairs Imprivata’s technology with Microsoft’s cloud identity platform, Azure Active Directory.
Through the first part of the collaboration, Imprivata has launched Healthcare Seamless SSO, which enables single sign-on into shared clinical workstations and mobile devices. The aim of the solution is to prevent clinical and non-clinical Microsoft users from having to repeatedly enter usernames and passwords.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“We’re delighted to announce this strategic collaboration with Microsoft and to introduce the Imprivata IAM Cloud Platform, which first brings the simplicity of Tap-In and Tap-Out to the cloud, and seamlessly supports access to Microsoft cloud applications like Microsoft Office 365 and more for our 1,945 healthcare customers,” Imprivata president and CEO Gus Malezis said in a statement. “Furthermore, the platform leverages the existing Imprivata investments of our joint customers, enhancing the ROI of their current and future technology investments.”
Last year, Lexington, Massachusetts-based Imprivata unveiled a solution that allows healthcare providers to quickly and safely access clinical devices. Dubbed Imprivata Mobile Device Access, it lets clinicians tap their badge to a mobile device, then single sign-on into their applications.
As for Microsoft, the tech company has recently announced it will pull the plug on some of its healthcare endeavors, including HealthVault, a web-based personal health record system, as well as its Health Dashboard site and Band apps. However, Microsoft is still involved in the space, in part through ties to companies like Redox and Oxford Biomedica.
Date: May 14, 2019
Source: MedCityNews
